Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria

Malar J. 2008 Dec 15:7:253. doi: 10.1186/1475-2875-7-253.

Abstract

Background: Molecular mechanisms involved in the pathogenesis of severe Plasmodium falciparum malaria (SM), are not yet fully understood. Both endothelin-1 (ET-1) and C-type natriuretic peptide (CNP) are produced by vascular endothelium and act locally as paracrine regulators of vascular tone, ET-1 being a potent vasoconstrictor and CNP having strong vasorelaxant properties.

Methods: Plasma levels of ET-1 and N-terminal fragments of CNP (NT-proCNP) were studied on admission and after 24 hours of treatment, using enzyme-linked-immunosorbent-assay (ELISA) technique, in Gabonese children with severe falciparum malaria (SM, n = 50), with uncomplicated malaria (UM, n = 39) and healthy controls (HC, n = 25).

Results: Compared to HC, malaria patients had significantly higher plasma levels of ET-1 and significantly lower levels of NT-proCNP (p < 0.001 and p < 0.024 respectively). Plasma levels of NT-proCNP were additionally decreased in SM patients compared to HC (p = 0.034), whereas UM was not significantly different to HC. In the SM group we found a trend towards lower ET-1 levels compared to UM (p = 0.085).

Conclusion: In the present study, an imbalance between the vasoconstricitve and vasorelaxant endothelium-derived substances ET-1 and CNP in the plasma of children with falciparum malaria is demonstrated, presumably in favor of vasoconstrictive and pro-inflammatory effects. These results may indicate involvement of ET-1 and CNP in malaria pathogenesis. Furthermore, results of lower ET-1 and CNP levels in SM may reflect endothelial cell damage.

MeSH terms

  • Analysis of Variance
  • Animals
  • Antimalarials / therapeutic use
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Drug Combinations
  • Endothelin-1 / blood*
  • Endothelium, Vascular / immunology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gabon / epidemiology
  • Humans
  • Infant
  • Malaria, Falciparum / blood
  • Malaria, Falciparum / drug therapy
  • Malaria, Falciparum / immunology*
  • Malaria, Falciparum / parasitology
  • Male
  • Natriuretic Peptide, C-Type / blood*
  • Plasmodium falciparum / immunology*
  • Pyrimethamine / therapeutic use
  • Quinine / therapeutic use
  • Statistics, Nonparametric
  • Sulfadoxine / therapeutic use

Substances

  • Antimalarials
  • Drug Combinations
  • Endothelin-1
  • Natriuretic Peptide, C-Type
  • fanasil, pyrimethamine drug combination
  • Sulfadoxine
  • Quinine
  • Pyrimethamine